Cartesian Therapeutics, Inc.RNACNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-43.90M
Near historical average
Average (9y)
$-41.84M
Historical baseline
Range
High:$14.54M
Low:$-86.42M
CAGR
+6.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-43.90M | +49.2% |
| 2023 | $-86.42M | -694.4% |
| 2022 | $14.54M | +416.2% |
| 2021 | $-4.60M | +91.9% |
| 2020 | $-56.82M | -8.3% |
| 2019 | $-52.45M | +19.3% |
| 2018 | $-65.02M | -1.9% |
| 2017 | $-63.78M | -84.0% |
| 2016 | $-34.67M | -37.0% |
| 2015 | $-25.30M | - |